« Data indicate risk of psychiatric readmission may increase shortly after childbirth | Main | Article discusses link between anxiety, depression, and heart risk »
March 30, 2009
FDA approves Lexapro for depression in adolescents
The AP (3/20) reported, "Forest Laboratories Inc. said Friday the Food and Drug Administration approved its depression and anxiety" medication "Lexapro [escitalopram oxalate] for use in children between the ages of 12 and 17 years old."
Forest "has come under scrutiny by the US government for its marketing practices, with the Justice Department in February filing a complaint alleging Lexapro and Celexa (citalopram hydrobromide) was promoted for use by children, even though it is not approved for their age group," although "Forest has denied it marketed the" medications "for any use other than the approved indications."
Posted by admin at March 30, 2009 04:56 PM